AR and benign prostatic hyperplasia: In one fluorescence in situ hybridization (FISH) study, the researchers found AR amplifications to be absent in the benign prostatic hyperplasia (BPH) samples, present in just 2% of the primary PCA tumors, but present in 23.4% of the CRPC tumors [11,15].